SHH and cancer: Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog (SHH) pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate [14].